HLS Therapeutics Inc. ( HLS:CA ) Q1 2026 Earnings Call May 15, 2026 10:00 AM EDT Company Participants Dave Mason - Investor Relations Officer Craig Millian - CEO & Director Brian Walsh - Chief Commercial Officer John Hanna - CFO & Non-Independent Director Conference Call Participants Michael Freeman - Raymond James Ltd., Research Division Presentation Operator Good morning, and welcome to the Q1 Fiscal 2026 financial results conference call for the HLS Therapeutics. At this point, I would like to turn the call over to David Mason, Investor Relations for the introductory remarks. Dave Mason Investor Relations Officer Good morning, everyone, and thank you for joining us today. With me on the call is Craig Millian, Chief Executive Officer; John Hanna, Chief Financial Officer; and Brian Walsh, Chief Commercial Officer. Earlier this morning, we issued a news release announcing our financial results for the 3 months ended March 31, 2026.…